Igor Feldman

Igor Feldman

Company: Verseau Therapeutics

Job title: Vice President, Head of Computational Biology

Bio:

Igor Feldman is a Co-Founder and has served as a Vice President and the Head of Computational Biology at Verseau Therapeutics since January 2017. Igor has held positions at Merck & Co., Rosetta Informatics, Jounce Therapeutics and Epizyme. He has been involved in discovery and clinical development using large omics datasets of human tumors, drug response biomarker discovery, novel target discovery in immuno-oncology and epigenetics and establishing computational infrastructure from the ground up for early discovery and development support in several biotech startup companies. He is an inventor on eight U.S. patents. Igor holds a B.S. in biology and a Ph.D. in systems biology from Columbia University.

Seminars:

Panel Discussion – Exploring Key Clinical Considerations for Macrophage-directed Therapies 3:45 pm

Download The Full Event Guide Read more

day: Day Two

Heterogeneity of Suppressive Mechanisms Employed by TumorAssociated Macrophages & their Relationship with Currently Approved PD-1 Inhibitors 10:15 am

Download The Full Event Guide Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.